Diffuse Midline Glioma, H3K27M-mutant Subtype, Confused for Viral Encephalitis: A Case Report

A B S T R A C T

The diffuse midline glioma, H3K27M-mutant subtype, occurs mainly in children as a result of mutations in the histone H3 (H3F3A) and HIST1H3B (K27M) genes and is characterized by diffuse tumor growth in central nervous system (CNS) midline structures. Due to its nonspecific clinical manifestations, viral encephalitis is often confused with other central nervous system diseases. In this case, we reported a young male patient who was admitted to the hospital chiefly complaining of “diplopia for more than two months and aggravated walking instability for more than 10 days”. After admission, relevant patient blood and cerebrospinal fluid (CSF) tests were completed, and no obvious abnormalities were found. Chest CT suggested pulmonary infection; magnetic resonance imaging (MRI) and contrast-enhanced CT, PET-CT and other imaging examinations of the head all indicated a high possibility of viral encephalitis. Symptoms of fever were improved in the patient after treatment with antiviral therapy and anti-infection therapy. However, symptoms of neurological function loss, such as double vision and adverse right limb movement, persisted. Finally, stereotactic biopsies of deep brain lesions were carried out and sent to the pathology department, which led to a diagnosis of diffuse midline glioma, H3K27M-mutant subtype (WHO IV). His family chose to perform conservative treatment in another hospital, and the patient died four months later. To conclude, when clinical symptoms of suspected viral encephalitis appear in the course of diffuse midline glioma, it can result in confusion regarding clinical diagnosis and treatment. Clinicians should ensure proper early recognition and identification of the disease.

Keywords

Diffuse midline glioma, H3K27M, viral encephalitis, stereotactic biopsy

Get access to the full version of this article.

Article Info

Article Type

Publication history

Copyright

Author Info

Cong Fu Yiyao Cao Zhijuan Chen Qing Yu Weidong Yang

Corresponding Author

Figures & Tables

Get access to the full version of this article.

References

1. Bailey S, Howman A, Wheatley K, Wherton D, Boota N et al. (2013) Diffuse intrinsic pontine glioma treated with prolonged temozolomide and radiotherapy--results of a United Kingdom phase II trial (CNS 2007 04). Eur J Cancer 49: 3856-3862. [Crossref]
2. Gielen GH, Gessi M, Hammes J, Kramm CM, Waha A et al. (2013) H3F3A K27M mutation in pediatric CNS tumors: a marker for diffuse high-grade astrocytomas. Am J Clin Pathol 139: 345-349. [Crossref]
3. Komori T (2017) The 2016 WHO Classification of Tumours of the Central Nervous System: The Major Points of Revision. Neurol Med Chir (Tokyo) 57: 301-311. [Crossref]
4. Louis DN, Perry A, Reifenberger G, Deimling AV, Figarella-Branger D et al. (2016) The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary. Acta Neuropathol 131: 803-820. [Crossref]
5. Feng J, Hao S, Pan C, Wang Y, Wu Z et al. (2015) The H3.3 K27M mutation results in a poorer prognosis in brainstem gliomas than thalamic gliomas in adults. Hum Pathol 46: 1626-1632. [Crossref]
6. Schwartzentruber J, Korshunov A, Liu XY, Jones DTW, Pfaff E et al. (2012) Driver mutations in histone H3.3 and chromatin remodelling genes in paediatric glioblastoma. Nature 482: 226-231. [Crossref]
7. Buckner JC, Shaw EG, Pugh SL, Chakravarti A, Gilbert MR et al. (2016) Radiation plus Procarbazine, CCNU, and Vincristine in Low-Grade Glioma. N Engl J Med 374: 1344-1355. [Crossref]
8. Hargrave D, Bartels U and Bouffet E (2006) Diffuse brainstem glioma in children: critical review of clinical trials. Lancet Oncol 7: 241-248. [Crossref]
9. Freeman CR and Farmer JP (1998) Pediatric brain stem gliomas: a review. Int J Radiat Oncol Biol Phys 40: 265-271. [Crossref]